• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上海方仓庇护医院 SARS-CoV-2 奥密克戎感染无症状和轻症患者的临床和病毒学特征。

Clinical and virological features of asymptomatic and mild symptomatic patients with SARS-CoV-2 Omicron infection at Shanghai Fangcang shelter hospital.

机构信息

Department of Internal Medicine, Central Medical Branch of Chinese PLA General Hospital, Beijing, People's Republic of China.

The Fourth Unit of Third Branch, Fangcang Shelter Hospital of National Exhibition and Convention Center, Shanghai, People's Republic of China.

出版信息

Immun Inflamm Dis. 2023 Sep;11(9):e1033. doi: 10.1002/iid3.1033.

DOI:10.1002/iid3.1033
PMID:37773703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10524057/
Abstract

OBJECTIVE

The objective of this study is to evaluate and compare clinical and virological characteristics of asymptomatic and mild symptomatic patients of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.2 variant infection and identify risk factors associated with the prolonged viral negative conversion duration.

METHODS

We conducted a retrospective observational study in a Shanghai (China) Fangcang shelter hospital from April 9 to May 17, 2022. The patient-related demographic or clinical data were retrospectively recorded. Comparisons of demographic and clinical characteristics between asymptomatic and mild-symptomatic patients were performed. Cox regression was performed to identify the risk factors of prolonged viral negative conversion duration.

RESULTS

A total of 551 patients confirmed with SARS-CoV-2 Omicron variant infection were enrolled in the study. Of these, 297 patients (53.9%) were asymptomatic and 254 patients (46.1%) had mild symptoms. When comparing the clinical and virological characteristics between the asymptomatic and mild symptomatic groups, several clinical parameters, including age, gender, time to viral clearance from the first positive swab, chronic comorbidities, and vaccination dose did not show statistically significant differences. In mild symptomatic patients, the median viral negative conversion duration (NCD) was 7 days (interquartile range [IQR]: 5-9), which was comparable to the median of 7 days (IQR: 5-10) in asymptomatic patients (p = .943). Multivariate Cox analysis revealed that patients age ≥ 60 years had a significantly higher hazard ratio (HR) for prolonged viral NCD (HR: 1.313; 95% confidence interval: 1.014-1.701, p = .039).

CONCLUSION

Asymptomatic and symptomatic patients with non-severe SARS-CoV-2 Omicron BA.2.2 variant infection have similar clinical features and virological courses. Old age was an independent risk factor for prolonged SARS-CoV-2 conversion time.

摘要

目的

本研究旨在评估和比较严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)奥密克戎 BA.2.2 变异感染的无症状和轻症患者的临床和病毒学特征,并确定与病毒转阴时间延长相关的危险因素。

方法

我们对 2022 年 4 月 9 日至 5 月 17 日期间在上海(中国)方仓庇护医院进行了一项回顾性观察性研究。回顾性记录了与患者相关的人口统计学或临床数据。比较了无症状和轻症患者的人口统计学和临床特征。采用 Cox 回归分析确定病毒转阴时间延长的危险因素。

结果

本研究共纳入 551 例确诊为 SARS-CoV-2 奥密克戎变异感染的患者。其中,297 例(53.9%)为无症状,254 例(46.1%)为轻症。比较无症状和轻症组的临床和病毒学特征时,年龄、性别、从首次阳性拭子到病毒清除的时间、慢性合并症和疫苗接种剂量等几个临床参数均无统计学差异。轻症患者的中位病毒转阴时间(NCD)为 7 天(IQR:5-9),与无症状患者的中位 NCD (7 天,IQR:5-10)相当(p = .943)。多因素 Cox 分析显示,年龄≥60 岁的患者病毒 NCD 延长的风险比(HR)显著更高(HR:1.313;95%置信区间:1.014-1.701,p = .039)。

结论

非重症 SARS-CoV-2 奥密克戎 BA.2.2 变异感染的无症状和轻症患者具有相似的临床特征和病毒学病程。年龄较大是 SARS-CoV-2 转换时间延长的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/3e227f5b7b38/IID3-11-e1033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/4dc7dfd3e038/IID3-11-e1033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/bfb5971c710b/IID3-11-e1033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/3e227f5b7b38/IID3-11-e1033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/4dc7dfd3e038/IID3-11-e1033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/bfb5971c710b/IID3-11-e1033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f8/10524057/3e227f5b7b38/IID3-11-e1033-g001.jpg

相似文献

1
Clinical and virological features of asymptomatic and mild symptomatic patients with SARS-CoV-2 Omicron infection at Shanghai Fangcang shelter hospital.上海方仓庇护医院 SARS-CoV-2 奥密克戎感染无症状和轻症患者的临床和病毒学特征。
Immun Inflamm Dis. 2023 Sep;11(9):e1033. doi: 10.1002/iid3.1033.
2
Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai.上海地区 SARS-CoV-2 奥密克戎变异株感染轻症和无症状患者病毒脱落时间的临床特征及影响因素分析。
Front Public Health. 2023 Jan 4;10:1073387. doi: 10.3389/fpubh.2022.1073387. eCollection 2022.
3
Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study.中国上海奥密克戎毒株流行期间无症状和轻症感染者疾病特征及病毒RNA衰减动态:一项回顾性队列研究
Int J Infect Dis. 2023 May;130:60-70. doi: 10.1016/j.ijid.2023.02.020. Epub 2023 Feb 25.
4
Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.非重症奥密克戎变异株 SARS-CoV-2 感染患者的免疫与病毒脱落持续时间的关系。
Front Public Health. 2022 Dec 22;10:1032957. doi: 10.3389/fpubh.2022.1032957. eCollection 2022.
5
Factors associated with negative conversion of viral RNA in hospitalized children infected with SARS-CoV-2 Omicron variant in Shanghai, China: a retrospective analysis.与中国上海住院感染 SARS-CoV-2 奥密克戎变异株的儿童病毒 RNA 阴性转化相关的因素:回顾性分析。
BMC Infect Dis. 2023 Apr 26;23(1):264. doi: 10.1186/s12879-023-08223-x.
6
[Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].[新型冠状病毒奥密克戎变异株感染儿童病毒核酸转阴的特征及相关因素]
Zhonghua Er Ke Za Zhi. 2022 Dec 2;60(12):1307-1311. doi: 10.3760/cma.j.cn112140-20220623-00582.
7
Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai.上海市 SARS-CoV-2 奥密克戎 BA.2 变异株轻症和无症状感染者的疫苗接种情况。
J Med Virol. 2023 May;95(5):e28767. doi: 10.1002/jmv.28767.
8
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
9
Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 Omicron variant infection: A retrospective study of 25207 cases in a Fangcang hospital.奥密克戎变异株感染患者疾病进展的临床特征及危险因素分析:方仓医院 25207 例回顾性研究
Front Cell Infect Microbiol. 2022 Oct 31;12:1009894. doi: 10.3389/fcimb.2022.1009894. eCollection 2022.
10
Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.化湿败毒颗粒治疗新型冠状病毒奥密克戎变异株感染患者的有效性和安全性:一项单中心回顾性队列研究。
Chin J Integr Med. 2024 Feb;30(2):107-114. doi: 10.1007/s11655-023-3549-8. Epub 2023 May 24.

引用本文的文献

1
Epidemiological Analysis of the COVID-19 Clusters in the Early Stages of the Epidemic in Shanghai, China: Pandemic-to-Epidemic Response Shift.中国上海疫情早期新冠疫情聚集性病例的流行病学分析:从大流行应对到疫情应对的转变
Trop Med Infect Dis. 2025 Jun 17;10(6):170. doi: 10.3390/tropicalmed10060170.
2
Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community Hospital during Omicron Predominance.在奥密克戎毒株占主导期间,一家农村社区医院爆发严重急性呼吸综合征冠状病毒2感染。
Microorganisms. 2024 Mar 28;12(4):686. doi: 10.3390/microorganisms12040686.

本文引用的文献

1
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.SARS-CoV-2 变异株的基因组监测:奥密克戎谱系的传播-美国,2022 年 1 月-2023 年 5 月。
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):651-656. doi: 10.15585/mmwr.mm7224a2.
2
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population.mRNA 和灭活 COVID-19 疫苗的有效性:在无感染史的香港人群中进行的一项病例对照研究。
J Infect. 2023 Aug;87(2):136-143. doi: 10.1016/j.jinf.2023.05.020. Epub 2023 May 26.
3
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study.
两到三剂科兴和国药疫苗对 COVID-19 相关住院、严重并发症和死亡率的效果下降:一项病例对照研究。
Emerg Microbes Infect. 2023 Dec;12(1):2209201. doi: 10.1080/22221751.2023.2209201.
4
Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.奥密克戎变异株在上呼吸道存活病毒和聚合酶链反应阳性的持续时间:系统评价和荟萃分析。
Int J Infect Dis. 2023 Apr;129:228-235. doi: 10.1016/j.ijid.2023.02.011. Epub 2023 Feb 18.
5
Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron.随着时间的推移,科兴和国药疫苗对奥密克戎患者严重结局的疫苗有效性估计
JAMA Netw Open. 2023 Feb 1;6(2):e2254777. doi: 10.1001/jamanetworkopen.2022.54777.
6
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.奥密克戎时代南非迅速变化的 SARS-CoV-2 免疫景观和严重程度。
Nat Commun. 2023 Jan 16;14(1):246. doi: 10.1038/s41467-022-35652-0.
7
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.印迹 SARS-CoV-2 体液免疫诱导奥密克戎 RBD 进化趋同。
Nature. 2023 Feb;614(7948):521-529. doi: 10.1038/s41586-022-05644-7. Epub 2022 Dec 19.
8
Comparison of secondary attack rate and viable virus shedding between patients with SARS-CoV-2 Delta and Omicron variants: A prospective cohort study.德尔塔和奥密克戎变异株患者的二代发病率和活病毒脱落率比较:一项前瞻性队列研究。
J Med Virol. 2023 Jan;95(1):e28369. doi: 10.1002/jmv.28369.
9
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株:影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.
10
Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 Omicron variant infection: A retrospective study of 25207 cases in a Fangcang hospital.奥密克戎变异株感染患者疾病进展的临床特征及危险因素分析:方仓医院 25207 例回顾性研究
Front Cell Infect Microbiol. 2022 Oct 31;12:1009894. doi: 10.3389/fcimb.2022.1009894. eCollection 2022.